vs
Healthpeak Properties（DOC）与艺达思集团（IEX）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是艺达思集团的1.8倍（$719.4M vs $398.4M），Healthpeak Properties净利率更高（73.2% vs 30.1%，领先43.1%），艺达思集团同比增速更快（16.7% vs 3.1%），Healthpeak Properties自由现金流更多（$357.0M vs $86.0M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs -29.4%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
艺达思集团是一家公开上市的工业制造企业，专注于流体系统与特种工程产品的研发和生产，产品广泛应用于工业制造、生命科学、食品安全等多个领域，可为全球各行业客户提供高性能定制化解决方案。
DOC vs IEX — 直观对比
营收规模更大
DOC
是对方的1.8倍
$398.4M
营收增速更快
IEX
高出13.6%
3.1%
净利率更高
DOC
高出43.1%
30.1%
自由现金流更多
DOC
多$271.0M
$86.0M
两年增速更快
DOC
近两年复合增速
-29.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $398.4M |
| 净利润 | $114.0M | $120.0M |
| 毛利率 | — | 99.9% |
| 营业利润率 | 17.4% | 43.3% |
| 净利率 | 73.2% | 30.1% |
| 营收同比 | 3.1% | 16.7% |
| 净利润同比 | 2406.4% | 25.7% |
| 每股收益（稀释后） | $0.16 | $1.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCIEX
| Q2 26 | — | $398.4M | ||
| Q1 26 | — | $407.7M | ||
| Q4 25 | $719.4M | $899.1M | ||
| Q3 25 | $705.9M | $878.7M | ||
| Q2 25 | $694.3M | $865.4M | ||
| Q1 25 | $702.9M | $814.3M | ||
| Q4 24 | $698.0M | $862.9M | ||
| Q3 24 | $700.4M | $798.2M |
净利润DOCIEX
| Q2 26 | — | $120.0M | ||
| Q1 26 | — | $128.3M | ||
| Q4 25 | $114.0M | $128.3M | ||
| Q3 25 | $-117.1M | $127.8M | ||
| Q2 25 | $31.7M | $131.6M | ||
| Q1 25 | $42.8M | $95.5M | ||
| Q4 24 | $4.5M | $123.2M | ||
| Q3 24 | $85.9M | $119.1M |
毛利率DOCIEX
| Q2 26 | — | 99.9% | ||
| Q1 26 | — | 94.9% | ||
| Q4 25 | — | 43.1% | ||
| Q3 25 | 58.6% | 44.5% | ||
| Q2 25 | 60.2% | 45.3% | ||
| Q1 25 | 61.1% | 45.3% | ||
| Q4 24 | 60.3% | 42.5% | ||
| Q3 24 | 60.0% | 44.3% |
营业利润率DOCIEX
| Q2 26 | — | 43.3% | ||
| Q1 26 | — | 45.0% | ||
| Q4 25 | 17.4% | 20.4% | ||
| Q3 25 | 9.2% | 21.1% | ||
| Q2 25 | 5.7% | 21.7% | ||
| Q1 25 | 7.7% | 17.4% | ||
| Q4 24 | -2.2% | 19.2% | ||
| Q3 24 | 14.1% | 21.0% |
净利率DOCIEX
| Q2 26 | — | 30.1% | ||
| Q1 26 | — | 31.5% | ||
| Q4 25 | 73.2% | 14.3% | ||
| Q3 25 | -16.6% | 14.5% | ||
| Q2 25 | 4.6% | 15.2% | ||
| Q1 25 | 6.1% | 11.7% | ||
| Q4 24 | 0.7% | 14.3% | ||
| Q3 24 | 12.3% | 14.9% |
每股收益（稀释后）DOCIEX
| Q2 26 | — | $1.61 | ||
| Q1 26 | — | $1.71 | ||
| Q4 25 | $0.16 | $1.71 | ||
| Q3 25 | $-0.17 | $1.70 | ||
| Q2 25 | $0.05 | $1.74 | ||
| Q1 25 | $0.06 | $1.26 | ||
| Q4 24 | $0.02 | $1.61 | ||
| Q3 24 | $0.12 | $1.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $586.2M |
| 总债务越低越好 | $9.8B | — |
| 股东权益账面价值 | $7.5B | $4.0B |
| 总资产 | $20.3B | $6.9B |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
现金及短期投资DOCIEX
| Q2 26 | — | $586.2M | ||
| Q1 26 | — | $580.0M | ||
| Q4 25 | $467.5M | $580.0M | ||
| Q3 25 | $91.0M | $593.8M | ||
| Q2 25 | $89.4M | $568.2M | ||
| Q1 25 | $70.6M | $594.1M | ||
| Q4 24 | $119.8M | $620.8M | ||
| Q3 24 | $180.4M | $633.2M |
总债务DOCIEX
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | $1.8B | ||
| Q3 25 | $9.1B | $1.9B | ||
| Q2 25 | $9.0B | $1.9B | ||
| Q1 25 | $8.9B | $2.0B | ||
| Q4 24 | $8.7B | $2.0B | ||
| Q3 24 | $8.6B | $2.1B |
股东权益DOCIEX
| Q2 26 | — | $4.0B | ||
| Q1 26 | — | $4.0B | ||
| Q4 25 | $7.5B | $4.0B | ||
| Q3 25 | $7.6B | $4.0B | ||
| Q2 25 | $7.9B | $4.0B | ||
| Q1 25 | $8.2B | $3.9B | ||
| Q4 24 | $8.4B | $3.8B | ||
| Q3 24 | $8.6B | $3.8B |
总资产DOCIEX
| Q2 26 | — | $6.9B | ||
| Q1 26 | — | $6.9B | ||
| Q4 25 | $20.3B | $6.9B | ||
| Q3 25 | $19.6B | $7.0B | ||
| Q2 25 | $19.8B | $6.9B | ||
| Q1 25 | $19.8B | $6.8B | ||
| Q4 24 | $19.9B | $6.7B | ||
| Q3 24 | $20.0B | $7.0B |
负债/权益比DOCIEX
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | 0.45× | ||
| Q3 25 | 1.20× | 0.48× | ||
| Q2 25 | 1.14× | 0.46× | ||
| Q1 25 | 1.08× | 0.50× | ||
| Q4 24 | 1.04× | 0.52× | ||
| Q3 24 | 1.00× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | — |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $86.0M |
| 自由现金流率自由现金流/营收 | 49.6% | 21.6% |
| 资本支出强度资本支出/营收 | 124.4% | 4.4% |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | $654.3M |
8季度趋势，按日历期对齐
经营现金流DOCIEX
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $209.5M | ||
| Q3 25 | $315.0M | $203.5M | ||
| Q2 25 | $363.5M | $161.7M | ||
| Q1 25 | $279.4M | $105.7M | ||
| Q4 24 | $1.1B | $172.6M | ||
| Q3 24 | $318.2M | $205.3M |
自由现金流DOCIEX
| Q2 26 | — | $86.0M | ||
| Q1 26 | — | $189.8M | ||
| Q4 25 | $357.0M | $189.8M | ||
| Q3 25 | — | $188.7M | ||
| Q2 25 | — | $146.9M | ||
| Q1 25 | — | $91.4M | ||
| Q4 24 | $333.7M | $157.1M | ||
| Q3 24 | — | $191.6M |
自由现金流率DOCIEX
| Q2 26 | — | 21.6% | ||
| Q1 26 | — | 46.6% | ||
| Q4 25 | 49.6% | 21.1% | ||
| Q3 25 | — | 21.5% | ||
| Q2 25 | — | 17.0% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | 47.8% | 18.2% | ||
| Q3 24 | — | 24.0% |
资本支出强度DOCIEX
| Q2 26 | — | 4.4% | ||
| Q1 26 | — | 15.6% | ||
| Q4 25 | 124.4% | 2.2% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | 105.6% | 1.8% | ||
| Q3 24 | — | 1.7% |
现金转化率DOCIEX
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | 1.63× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | 11.48× | 1.23× | ||
| Q1 25 | 6.52× | 1.11× | ||
| Q4 24 | 235.43× | 1.40× | ||
| Q3 24 | 3.71× | 1.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
